Can Unresolved Infection Precipitate Autoimmune Disease?

  • D. J. B. Marks
  • N. A. Mitchison
  • A. W. Segal
  • J. Sieper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 305)

Abstract

Autoimmune diseases are frequently postulated to arise as post-infectious phenomena. Here we survey the evidence supporting these theories, with particular emphasis on Crohn’s disease and ankylosing spondylitis. Direct proof that infection establishes persistent autoimmunity remains lacking, although it may provoke a prolonged inflammatory response when occurring on a susceptible immunological background. The argument of infective causality is by nomeans trivial, since it carries important consequences for the safety of vaccine development.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alderuccio F, Cataldo V, van Driel IR et al. (2000) Tolerance and autoimmunity to a gastritogenic peptide in TCR transgenic mice. Int Immunol 12:343–352PubMedGoogle Scholar
  2. 2.
    Alpan O, Bachelder E, Isil E et al. (2004) ‘Educated’ dendritic cells act as messengers from memory to naive T helper cells. Nat Immunol 5:615–622PubMedGoogle Scholar
  3. 3.
    Atagunduz P, Appel H, Kuon W et al. (2005) HLA-B27 restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. J Arthritis Rheum 52:892–901Google Scholar
  4. 4.
    Bachmaier K, Krawczyk C, Sasaki T et al. (2000) Negative regulation of lymphocyte activation and autoimmunity by themolecular adaptor Cbl-b. Nature 403:211–216PubMedGoogle Scholar
  5. 5.
    Bardos T, Szabo Z, Czipri M et al. (2005) A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis 64:981–987PubMedGoogle Scholar
  6. 6.
    Bennett CL, Christie J, Ramsdell F et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21PubMedGoogle Scholar
  7. 7.
    Benoist C, Mathis D (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2:797–801PubMedGoogle Scholar
  8. 8.
    Bettelli E, Pagany M, Weiner HL et al. (2003) Myelin oligodendrocyte glycoproteinspecific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197:1073–1081PubMedGoogle Scholar
  9. 9.
    Bollow MFT, Fischer T, Reisshauer H et al. (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis: cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59:135–140PubMedGoogle Scholar
  10. 10.
    Brand DD, Myers LK, Whittington KB et al. (2002) Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J Immunol 168:490–498PubMedGoogle Scholar
  11. 11.
    Braun J, Bollow M, Eggens U et al. (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 37:1039–1045PubMedGoogle Scholar
  12. 12.
    Braun J, Bollow M, Neure L et al. (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499–505PubMedGoogle Scholar
  13. 13.
    Braun J, Bollow M, Remlinger G et al. (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58–67PubMedGoogle Scholar
  14. 14.
    Braun J, Tuszewski M, Ehlers S et al. (1997) Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. II. Examination of sacroiliac and knee joint biopsies of patients with spondyloarthropathies and other arthritides. J Rheumatol 24:1101–1105PubMedGoogle Scholar
  15. 15.
    Brewerton DA, Hart FD, Nichols A et al (1973) Ankylosing spondylitis and HL-A 27. Lancet 28:904–907Google Scholar
  16. 16.
    Bridger S, Lee JC, Bjarnasson I et al. (2002) In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn’s disease and non-smokers develop ulcerative colitis. Gut 51:21–25PubMedGoogle Scholar
  17. 17.
    Brunner MC, Mitchison NA, Schneider SC et al. (1994) Immunoregulation mediated by T-cell clusters. Folia Biol (Praha) 40:359–369Google Scholar
  18. 18.
    Candon S, McHugh RS, Foucras G et al. (2004) Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice. J Immunol 172:2917–2924PubMedGoogle Scholar
  19. 19.
    Chacon O, Bermudez LE, Barletta RG (2004) Johne’s disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol 58:329–363PubMedGoogle Scholar
  20. 20.
    Chiang YJ, Kole HK, Brown K et al. (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403:216–220PubMedGoogle Scholar
  21. 21.
    Chiodini RJ, Van Kruiningen HJ, Thayer WR et al. (1988) Spheroplastic phase of mycobacteria isolated from patients with Crohn’s disease. J Clin Microbiol. 24:357–363Google Scholar
  22. 22.
    Claudepierre P, Gueguen A, Ladjouze A et al (1995) Predictive factors of severity of spondyloarthropathy in North Africa. Br J Rheumatol 34:1139–1145PubMedGoogle Scholar
  23. 23.
    Cooper PJ (1996) Autoimmunity and onchocerciasis. Lancet 347:404PubMedGoogle Scholar
  24. 24.
    Creusot RJ, Mitchison NA (2004) How DCs control cross-regulation between lymphocytes. Trends Immunol 25:126–131PubMedGoogle Scholar
  25. 25.
    Curran FT, Allan RN (1991) Superoxide production by Crohn’s disease neutrophils. Gut 32:399–402PubMedGoogle Scholar
  26. 26.
    D’Agata ID, Paradis K, Chad Z et al. (1996) Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 39:605–608PubMedGoogle Scholar
  27. 27.
    Dalziel TK (1913) Chronic intestinal enteritis. BMJ ii:1068–1070Google Scholar
  28. 28.
    Daniel-Ribeiro CT, Zanini G (2000) Autoimmunity and malaria: what are they doing together? Acta Trop 76:205–221PubMedGoogle Scholar
  29. 29.
    Dean L, McEntyre JR (2004). The genetic landscapeof diabetes [Internet]. National Library of Medicine (US), NCBI, Bethesda, MDGoogle Scholar
  30. 30.
    Deshpande SP, Lee S, Zheng M et al. (2001) Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. JVirol 75:3077–3088Google Scholar
  31. 31.
    Dieckgraefe BK, Korzenik J (2002) Treatment of active Crohn’s disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 360:1478–1480PubMedGoogle Scholar
  32. 32.
    Dieckgraefe BK, Korzenik JR, Husain A et al (2002) Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr 161: S88–S92PubMedGoogle Scholar
  33. 33.
    DiPaolo RJ, Unanue ER (2001) The level of peptide-MHC complex determines the susceptibility to autoimmune diabetes: studies in HEL transgenic mice. Eur J Immunol 31:3453–3459PubMedGoogle Scholar
  34. 34.
    Eggena MP, Walker LS, Nagabhusanam V et al. (2004) Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J Exp Med 199:1725–1730PubMedGoogle Scholar
  35. 35.
    Ekbom A, Montgomery SM (2004) Environmental risk factors (excluding tobacco andmicroorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol. 18:497–508PubMedGoogle Scholar
  36. 36.
    El Zaatari, FA, Osato MS (2001) Etiology of Crohn’s disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med 7:247–252PubMedGoogle Scholar
  37. 37.
    Ellmerich S, Takacs K, Mysko M et al. (2004) Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur J Immunol 34:1839–1848PubMedGoogle Scholar
  38. 38.
    Emmanuel AV, Kamm MA (1999) Laser Doppler measurement of rectal mucosal blood flow. Gut 45:64–69PubMedGoogle Scholar
  39. 39.
    Faria AM, Maron R, Ficker SM et al. (2003) Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J Autoimmun 20:135–145PubMedGoogle Scholar
  40. 40.
    Fata F, Myers P AJ, Grinberg M et al. (1997) Cyclic neutropenia in Crohn’s ileocolitis: efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol 24:253–256PubMedGoogle Scholar
  41. 41.
    Fikrig E, Barthold SW, Kantor FS et al. (1992) Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun 60:773–777PubMedGoogle Scholar
  42. 42.
    Finne J, Bitter-Suermann D, Goridis C et al. (1987) An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 138:4402–4407PubMedGoogle Scholar
  43. 43.
    Forster I, Hirose R, Arbeit JM et al. (1995) Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigen. Immunity 2:573–285PubMedGoogle Scholar
  44. 44.
    Franchimont D, Vermeire S (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4. Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut 53:987–992PubMedGoogle Scholar
  45. 45.
    Fritz RB, Chou CH, McFralin DE (1983) Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol 130:1024–1026PubMedGoogle Scholar
  46. 46.
    Gale EA, Atkinson M (2004) A piece of nucleic acid surrounded by controversy: coxsackievirus and the causes of Type 1 diabetes. Diabet Med 21:503–506PubMedGoogle Scholar
  47. 47.
    Gallin MY, Jacobi AB, Buttner DW et al. (1995) Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda). J Exp Med. 182:41–47PubMedGoogle Scholar
  48. 48.
    Ghosh S, Armitage E, Wilson D et al. (2001) Detection of persistent measles virus infection in Crohn’s disease: current status of experimental work. Gut 48:748–752PubMedGoogle Scholar
  49. 49.
    Good MF (1995) What can a worm teach us about autoimmunity? Lancet 346:1311–1312PubMedGoogle Scholar
  50. 50.
    Green J, Casabonne D, Newton R (2004) Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med. 21:507–514PubMedGoogle Scholar
  51. 51.
    Gronski MA, Boulter JM, Moskophidis D et al. (2004) TCR affinity and negative regulation limit autoimmunity. Nat Med 10:1234–1239PubMedGoogle Scholar
  52. 52.
    Gui GP, Thomas PR, Tizard ML et al. (1997) Two-year-outcomes analysis of Crohn’s disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 39:393–400PubMedGoogle Scholar
  53. 53.
    Guilherme L, Kalil J (2004) Rheumatic fever: from sore throat to autoimmune heart lesions. Int Arch Allergy Immunol 134:56–64PubMedGoogle Scholar
  54. 54.
    Hajjaj-Hassouni N, Maetzel A, Dougados M (1993) Comparison of patients evaluated for spondyloarthropathy in France and Morocco. Rev Rhum Ed Fr 60:420–425PubMedGoogle Scholar
  55. 55.
    Hermon-Taylor J, Barnes N, Clarke C et al. (1998) Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn’s disease. BMJ 316:449–453PubMedGoogle Scholar
  56. 56.
    Hernandez-Fuentes MP, Lechler RI (2005) Chronic graft loss. Contrib Nephrol 146:54–64PubMedGoogle Scholar
  57. 57.
    Hesse M, Mitchison NA (2000) Relapsing arthritis induced by cell transfer from collagen-immunised mice. Autoimmunity 32:27–32PubMedGoogle Scholar
  58. 58.
    Huang F, Zhang J, Zju J et al. (2003) Juvenile spondyloarthropathies: the Chinese experience. Rheum Dis Clin North Am 29:531–547PubMedGoogle Scholar
  59. 59.
    Hueber W, Zeng D, Strober S et al. (2004) Interferon-alpha-inducible proteins are novel autoantigens in murine lupus. Arthritis Rheum 50:3239–3249PubMedGoogle Scholar
  60. 60.
    Hugot JP, Chamaillard M, Zouali H et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603PubMedGoogle Scholar
  61. 61.
    Ishii E, Matui T, Iida M et al. (1987) Chediak-Higashi syndrome with intestinal complication. Report of a case. J Clin Gastroenterol 9:556–558PubMedGoogle Scholar
  62. 62.
    Kalil J, Cunha-Neto E (1996) Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last? Parasitol Today 12:396–399PubMedGoogle Scholar
  63. 63.
    Kierszenbaum F (2003) Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol Med Microbiol 37:1–11PubMedGoogle Scholar
  64. 64.
    Klein W, Tromm A, Griga T et al. (2002) A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 37:189–191PubMedGoogle Scholar
  65. 65.
    Kouskoff V, Korganow AS, Duchatelle V et al. (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811–822PubMedGoogle Scholar
  66. 66.
    Kuon W, Sieper J (2003) Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis. Rheum Dis Clin North Am 29:595–611PubMedGoogle Scholar
  67. 67.
    Lamport RD, Katz S, Eskreis D (1992) Crohn’s disease associated with cyclic neutropenia. Am J Gastroenterol. 87:1638–1642PubMedGoogle Scholar
  68. 68.
    Lamps LW, Madhusudhan KT, Havens JM et al. (2003) Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn’s disease. Am J Surg Pathol 27:220–227PubMedGoogle Scholar
  69. 69.
    Lau CS, Burgos-Vargas R, Louthrenoo W et al. (1998) Features of spondyloarthritis around the world. Rheum Dis Clin North Am 24:753–770PubMedGoogle Scholar
  70. 70.
    Leirisalo-Repo M (1998) Prognosis, course of disease, and treatment of the spondyloarthropathies. Rheum Dis Clin North Am 24:737–751PubMedGoogle Scholar
  71. 71.
    Leon JS, Daniels MD, Toriello KM et al. (2004) A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun 72:3410–3417PubMedGoogle Scholar
  72. 72.
    Leon K, Faro J, Lage A et al (2004) Inverse correlation between the incidences of autoimmune disease and infection predicted by a model of T cell mediated tolerance. J Autoimmun 22:31–42PubMedGoogle Scholar
  73. 73.
    Liu Y, Van Kruiningen HJ, West AB et al. (1995) Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease. Gastroenterology 108:1396–1404PubMedGoogle Scholar
  74. 74.
    Lombardi G, Sidhu S, Batchelor RJ et al. (1994) Anergic T cells as suppressor cells in vitro. Science 264:1587–1589PubMedGoogle Scholar
  75. 75.
    Lu S, Carlsen S, Hansson AS et al. (2002) Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen. J Autoimmun 18:199–211PubMedGoogle Scholar
  76. 76.
    Maksymowych WP (2000) Ankylosing spondylitis—at the interface of bone and cartilage. J Rheumatol 27:2295–2301PubMedGoogle Scholar
  77. 77.
    Manavalan JS, Kim-Schulze S, Scotto L et al. (2004) Alloantigen specific CD8+CD28− FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16:1055–1068PubMedGoogle Scholar
  78. 78.
    May E, Dulphy N, Fauendorf E et al. (2002) Conserved TCR beta chain usage in reactive arthritis: evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 60:299–308PubMedGoogle Scholar
  79. 79.
    May E, Marker-Hermann E, Wittig BM et al. (2000) Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology 119:1745–1755PubMedGoogle Scholar
  80. 80.
    McGargill MA, Mayerova D, Stefanski HE et al. (2002) A spontaneous CD8. T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J Immunol 169:2141–7PubMedGoogle Scholar
  81. 81.
    McGonagle D, Emery P (1999) Classification of inflammatory arthritis. Lancet 353:671PubMedGoogle Scholar
  82. 82.
    Meilof JF, Van der Lelij A, Rokeach LA et al. (1993) Autoimmunity and filariasis. Autoantibodies against cytoplasmic cellular proteins in sera of patients with onchocerciasis. J Immunol 151:5800–9PubMedGoogle Scholar
  83. 83.
    Mendel I, Natarajan K, Ben-Nun A et al (2004) A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein. J Neuroimmunol 10–21Google Scholar
  84. 84.
    Mitchison NA (1993) A walk round the edges of self tolerance. Ann Rheum Dis 52: S3–5PubMedGoogle Scholar
  85. 85.
    Morain CO, Segal AA, Walker D et al. (1981) Abnormalities of neutrophil function do not cause the migration defect in Crohn’s disease. Gut 22:817–822PubMedGoogle Scholar
  86. 86.
    Nahar IK, Shojania K (2003) Infliximab treatment of rheumatoid arthritis and Crohn’s disease. Ann Pharmacother 37:1256–1265PubMedGoogle Scholar
  87. 87.
    Naser SA, Ghobrial G, Romero C et al. (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet 364:1039–1044PubMedGoogle Scholar
  88. 88.
    Ogura Y, Bonen DK, Inohara N et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606PubMedGoogle Scholar
  89. 89.
    Olhagen B (1983) Urogenital syndromes and spondarthritis. Br J Rheumatol 22:33–40PubMedGoogle Scholar
  90. 90.
    Oono T, Fukui Y, Masuko S et al. (2001) Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide. J Clin Invest 108:1589–1596PubMedGoogle Scholar
  91. 91.
    Pette M, Fujita K, Wilkinson D et al. (1990) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context ofHLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A 87:7968–7972PubMedGoogle Scholar
  92. 92.
    Pontes-de-Carvalho L, Santana CC, Soares MB et al. (2002) Experimental chronic Chagas’ disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 18:131–138PubMedGoogle Scholar
  93. 93.
    Purrmann J, Zeidler H, Bertrams J et al. (1988) HLA antigens in ankylosing spondylitis associated with Crohn’s disease. Increased frequency of the HLA phenotype B27, B44. J Rheumatol 15:1658–1661PubMedGoogle Scholar
  94. 94.
    Quirke P (2001) Mycobacterium avium subspecies paratuberculosis is a cause of Crohn’s disease. Gut 49:757–760PubMedGoogle Scholar
  95. 95.
    Reeves EP, Lu H, Jacobs HL et al. (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416:291–297PubMedGoogle Scholar
  96. 96.
    Rodriguez DS, Jankowska-Gan E, Haynes LD et al. (2004) Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant 4:537–543PubMedGoogle Scholar
  97. 97.
    Rose NR (1998) The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 10:5–13PubMedGoogle Scholar
  98. 98.
    Rose NR, Hill SL (1996) The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol. 80: S92–S99PubMedGoogle Scholar
  99. 99.
    Rutgeerts P, Goboes K, Peeters M et al. (1991) Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet 338:771–774PubMedGoogle Scholar
  100. 100.
    Ryan P, Kelly RG, Lee G et al. (2004) Bacterial DNA within granulomas of patients with Crohn’s disease—detection by laser capture microdissection and PCR. Am J Gastroenterol 99:1539–1543PubMedGoogle Scholar
  101. 101.
    Scheffold A, Hühn J, Hoffer T (2005) Regulation of CD4+CD25+Treg activity: it takes (IL-) two to tango. Europ J Immunol 35:1336–1341Google Scholar
  102. 102.
    Schneider SC, Mitchison NA (1995) Self-reactive T cell hybridomas and tolerance. Same range of antigen dose dependence but higher numbers of self-reactive T cell hybridomas from mice in which self-tolerance has been broken by antiserum treatment. J Immunol 154:3796–3805PubMedGoogle Scholar
  103. 103.
    Schwimmbeck PL, Badorff C, Rohn G et al. (1996) The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 54:117–125PubMedGoogle Scholar
  104. 104.
    Segal AW, Loewi G (1976) Neutrophil dysfunction in Crohn’s disease. Lancet 2:219–221PubMedGoogle Scholar
  105. 105.
    Shafran I, Kugler L, El-Zaateri LA et al. (2002) Open clinical trial of rifabutin and clarithromycin therapy in Crohn’s disease. Dig Liver Dis 34:22–28PubMedGoogle Scholar
  106. 106.
    Sho M, Yamada A, Najafian M et al. (2002) Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 169:3744–3751PubMedGoogle Scholar
  107. 107.
    Sieper J, Braun J (1995) Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 38:1547–1554PubMedGoogle Scholar
  108. 108.
    Stevens C, Peppercorn MA, Grand RJ (1991) Crohn’s disease associated with autoimmune neutropenia. J Clin Gastroenterol 13:328–330PubMedGoogle Scholar
  109. 109.
    Summers RW, Elliott DE, Urban JF Jr et al (2005) Trichuris suis therapy in Crohn’s disease. Gut 54:87–90PubMedGoogle Scholar
  110. 110.
    Tarleton RL, Zhang L, Downs MO (1997) “Autoimmune rejection” of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci U S A 94:3932–3937PubMedGoogle Scholar
  111. 111.
    Thrasher AJ, Keep NH, Wientjes F et al. (1994) Chronic granulomatous disease. Biochim Biophys Acta 1227:1–24PubMedGoogle Scholar
  112. 112.
    Van Kruiningen HJ (1999) Lack of support for a common etiology in Johne’s disease of animals and Crohn’s disease in humans. Inflamm Bowel Dis 5:183–191PubMedGoogle Scholar
  113. 113.
    Vannier JP, Arnaud-Battandier F, Ricour C et al. (1982) Chronic neutropenia and Crohn’s disease in childhood. Report of 2 cases. Arch Fr Pediatr 39:367–370PubMedGoogle Scholar
  114. 114.
    Varela-Calvino R, Ellis R, Sgarbi G et al. (2002) Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes 51:1745–1753PubMedGoogle Scholar
  115. 115.
    Verjans GM, Remeijer L, Mooy CM et al. (2000) Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells. Invest Ophthalmol Vis Sci 41:2607–2612PubMedGoogle Scholar
  116. 116.
    Waldner H, Whitters MJ, Sobel RA et al. (2000) Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci U S A 97:3412–3417PubMedGoogle Scholar
  117. 117.
    Wieringa MH, Vermeire PA, Brunekreef B et al. (2001) Increased occurrence of asthma and allergy: critical appraisal of studies using allergic sensitization, bronchial hyper-responsiveness and lung function measurements. Clin Exp Allergy 31:1553–1563PubMedGoogle Scholar
  118. 118.
    Worsaae N, Staehr JK (1982) Impaired in vitro function of neutrophils in Crohn’s disease. Scand J Gastroenterol 17:91–96PubMedGoogle Scholar
  119. 119.
    Yli-Kerttula T, Luukkainen R, Yli-Kerttula U et al. (2000) Effect of a three-month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 59:565–570PubMedGoogle Scholar
  120. 120.
    Yli-Kerttula T, Luukkainen R, Yli-Kerttula U et al. (2003) Effect of a three-month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum 62:880–884Google Scholar
  121. 121.
    Zhang Y (2003) Animal models of inflammatory spinal and sacroiliac joint diseases. Rheum Dis Clin North Am 29:631–645PubMedGoogle Scholar
  122. 122.
    Zhao ZS, Granucci F, Yeh L (1998) Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279:1344–1347PubMedGoogle Scholar
  123. 123.
    Zou J, Appel H, Rudwaleit M et al. (2004) Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis. Ann Rheum Dis 64:722–729PubMedGoogle Scholar
  124. 124.
    Zou J, Zhang Y, Rudwaleit M et al. (2003) Predominant cellular immune response to the cartilage autoantigenicG1 aggrecan in ankylosing spondylitis and rheumatoid arthritis. Rheumatology (Oxford) 42:846–855PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • D. J. B. Marks
    • 1
  • N. A. Mitchison
    • 2
  • A. W. Segal
    • 1
  • J. Sieper
    • 3
  1. 1.Centre for Molecular MedicineUniversity College LondonLondonUK
  2. 2.Department of Immunology, Windeyer Institute of Medical ScienceUniversity College LondonLondonUK
  3. 3.Department of Rheumatology, Charite BerlinCampus Benjamin FranklinBerlinGermany

Personalised recommendations